OTTAWA, July 30 (LifeSiteNews.com) – America’s Food and Drug Administration (FDA) has approved Plan B, the first progestin-only emergency contraceptive concoction. The pro-abortion Women’s Capital Corporation (WCC), which is the U.S. distributor for Plan B, praised the decision in a statement issued on Wednesday. Sharon Camp, president of the organization, said: “We are really excited to be able to provide this important advance in emergency contraception to American women.”
Although calling it an advance because it apparently causes less side-effects than other abortifacient mixtures, WCC admits that women could experience nausea, vomitting, lower abdominal pain, fatigue, headaches, dizziness, breast tenderness, and menstrual changes. Defining pregnancy as beginning at implantation, the organization claims that it does not work after women become pregnant. The pro-abortion outfit, however, is not sure exactly how the concoction works. It “is believed to act,” reads the WCC statement, “mainly by preventing ovulation or fertilization,” but it also “may inhibit implantation.” “The Plan B regimen was tested by the World Health Organization (WHO) in almost 3,000 women in 15 countries, including the United States and Canada,” notes WCC.
The organization quoted Dr. Edith Guilbert, a leading Canadian physician who took part in the most recent WHO study, predicting acceptance of Plan B in Canada. “I believe the new progestin-only emergency contraceptive will be readily accepted by health care providers in both the United States and Canada,” she said, expressing hope that this “new and better product will help increase awareness of emergency contraception.” “WCC is a privately held company, organized in 1997, to bring Plan B to the U.S. and Canadian markets, and to develop other critically-needed reproductive health products for women,” reads the company’s statement. “Financing for Plan B has come, in large part, from U.S. foundations, such as the David and Lucile Packard Foundation, the Wallace Alexander Gerbode Foundation, and the Compton Foundation.”